Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab

British Journal of Ophthalmology

Volumn 92, Issue 9, 2008, Pages 1244-1247

  Figueroa, M S ^a,b   Noval, S ^b,c   Contreras, I ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b VISSUM Corporacion Oftalmologica   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CIPROFLOXACIN; OFTACILOX; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOMICROSCOPY; CHOROID DISEASE; CLINICAL ARTICLE; EYE DISEASE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PERIPAPILLARY CHOROIDAL NEOVASCULAR MEMBRANE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE; VISUAL ACUITY; VITRECTOMY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 51149111416     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2008.144196     Document Type: Article

References (25)

1. Turcotte P, Maguire MG, Fine SL Visual results after laser treatment for peripapillary choroidal neovascular membranes. Retina 1991;11:295-300.
2. Liu JC, Boldt HC, Folk JC, et al. Photodynamic therapy of subfoveal and juxtafoveal choroidal neovascularization in ocular histoplasmosis syndrome: a retrospective case series. Retina 2004;24:863-70.
3. Rosenblatt BJ, Shah GK, Blinder K. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization. Retina 2005;25:33-7.
4. Blinder KJ, Shah GK, Thomas MA, et al. Surgical removal of peripapillary choroidal neovascularization associated with age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:358-64.
5. Aisenbrey S, Gelisken F, Szurman P. et al. Surgical treatment of peripapillary choroidal neovascularization. Br J Ophthalmol 2007;91:1027-30.
6. Bains HS, Patel MR, Singh H, et al. Surgical treatment of extensive peripapillary choroidal neovascularization in elderly patients. Retina 2003;23:469-74.
7. Mateo C, Moreno JG, Lechuga M, et al. Surgical removal of peripapillary choroidal neovascularization associated with optic nerve drusen. Retina 2004;24:739-45.
8. Lazic R, Gabric N. Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007;245:68-73.
9. Mones JM, Lopez MA, Prieto JA, et al. Extrafoveal choroidal neovascularization secondary to wet age-related macular degeneration treated with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging 2007;38:226-8.
10. Spaide RF, Laud K, Fine HF, ef al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006;26:383-90.
11. Chan WM, Lai TY, Liu DT, et al. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007;143:977-83.
12. Lazic R, Gabric N. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration. Ophthalmology 2007;114:1179-85.
13. Emerson MV, Lauer AK, Flaxel CJ, et al. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 2007;27:439-44.
14. Browning DJ, Fraser CM. Ocular conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes. Ophthalmology 2005;112:1054-61.
15. Macular Photocoagulation Study Group. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Arch Ophthalmol 1995;113:56-61.
16. Soliman W, Lund-Andersen H, Larsen M. Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization. Acta Ophthalmol Scand 2006;84:707-8.
17. Smith BT, Joseph DP, Grand MG. Treatment of neovascular age-related macular degeneration: past, present and future directions. Curr Opin Ophthalmol 2007;18:240-4.
18. Ahmadieh H, Taei R, Soheilian M, et al. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration. BMC Ophthalmol 2007;7:10.
19. Schadlu R, Kymes SM, Apte RS. Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response. Graefes Arch Clin Exp Ophthalmol 2007;245:1667-72.
20. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005;112:301-4.
21. Almony A, Thomas MA, Atebara NH, et al. Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome. Ophthalmology 2008;115:540-5.
22. Kaiser PK. Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases. Am J Ophthalmol 2006;142:660-8.
23. Pedersen R, Soliman W, Lund-Andersen H, et al. Treatment of choroidal neovascularization using intravitreal bevacizumab. Acta Ophthalmol Scand 2007;85:526-33.
24. Spandau UH, Jonas JB. Intravitreal bevacizumab for peripapillary classic subretinal neovascularization. Acta Ophthalmol Scand 2007;85:340-1.
25. Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 2008;246:81-7.